General Resources / Legal Resources / Medical
Resources / Briefing Papers / State Activity
Hospital Closures / Preventable
Tragedies / Press Room / Search
Our Site / Home
Sexual Victimization in Women With Schizophrenia and Bipolar Disorder. J.-M. Darvez-Bornoz, T. Lemperiere, A. Degiovanni, P. Grillard. Social Psychiatry and Psychiatric Epidemiology 30:78-84, 1995.
Importance: The incidence of rape among
adult women with schizophrenia was almost 3 times higher and among adult women with
bipolar disorder 2 times higher than among the general population. Among those with
schizophrenia, the majority had been raped multiple times, and rape was associated with
being more severely mentally ill.
Summary: In France, 64 women with schizophrenia and 26 women
with bipolar disorder were carefully questioned regarding their sexual histories. A total
of 14 (22 percent) of the women with schizophrenia and 4 (15 percent) of the women with
bipolar disorder had been raped as adults, compared with a rate of 8 percent in the
general population. Nine of the 14 women with schizophrenia who had been raped had been
raped multiple times. According to the authors, the women with schizophrenia who had been
raped "belonged mainly to the group of schizophrenics with the longest duration of
hospitalization, that is to say, probably to the most chronically and severely ill
group."
general
resources | legal resources | medical
resources | briefing papers | state activity
hospital closures | preventable
tragedies | press room | search
| home
The contents of TAC's website are copyrighted by the Treatment Advocacy Center unless otherwise indicated. All rights reserved and content may be reproduced, downloaded, disseminated, or transferred, for single use, or by nonprofit organizations for educational purposes only, if correct attribution is made. TAC is an I.R.C. § 501(c)(3) tax-exempt corporation. Donations are appreciated and are eligible for the charitable contribution deduction under the provisions of I.R.C. § 170. Please note that TAC does not accept funding from pharmaceutical companies or entities involved in the sale, marketing, or distribution of such products. Treatment Advocacy Center (TAC), 200 N. Glebe Road, Suite 730, Arlington, VA 22203 703 294 6001/6002 (phone) | 703 294 6010 (fax) | www.treatmentadvocacycenter.org (website) info@treatmentadvocacycenter.org (general email) | press@treatmentadvocacycenter.org (press contact) webmaster@treatmentadvocacycenter.org (webmaster) |